Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SVRA Savara Inc

休市中 11-13 16:00:00 EST

4.64

-0.08

-1.69%

盘后4.66

+0.02+0.43%

19:44 EST

最高4.85	最低4.58	成交量323.18万
今开4.80	昨收4.72	日振幅5.61%
总市值10.25亿	流通市值9.94亿	总股本2.21亿
成交额1,517万	换手率1.51%	流通股本2.14亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SVRA","market":"US","secType":"STK","nameCN":"Savara Inc","latestPrice":4.64,"timestamp":1794603600000,"preClose":4.72,"halted":0,"volume":3231792,"hourTrading":{"tag":"盘后","latestPrice":4.66,"preClose":4.64,"latestTime":"19:44 EST","volume":37256,"amount":172983.0947,"timestamp":1794617092411,"change":0.02,"changeRate":0.00431,"amplitude":0.012931},"delay":0,"changeRate":-0.0169491525423729,"floatShares":214228727,"shares":221000000,"eps":-0.609786,"marketStatus":"休市中","change":-0.08,"latestTime":"11-13 16:00:00 EST","open":4.8,"high":4.845,"low":4.58,"amount":15168186.294768,"amplitude":0.056144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.609786,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.72,"preHourTrading":{"tag":"盘前","latestPrice":4.79,"preClose":4.72,"latestTime":"09:29 EST","volume":11090,"amount":53184.509293,"timestamp":1794580199999,"change":0.07,"changeRate":0.014831,"amplitude":0.076271},"postHourTrading":{"tag":"盘后","latestPrice":4.66,"preClose":4.64,"latestTime":"19:44 EST","volume":37256,"amount":172983.0947,"timestamp":1794617092411,"change":0.02,"changeRate":0.00431,"amplitude":0.012931},"volumeRatio":0.8111214722120673,"impliedVol":1.729,"impliedVolPercentile":0.5976},"requestUrl":"/m/hq/s/SVRA","defaultTab":"news","newsList":[{"id":"1174889253","title":"Savara将在2026年欧洲呼吸学会大会上再度呈现Molgramostim吸入溶液治疗自身免疫性肺泡蛋白沉积症（aPAP）的III期临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1174889253","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174889253?lang=zh_cn&edition=full","pubTime":"2026-08-25 04:06","pubTimestamp":1787601973,"startTime":"0","endTime":"0","summary":"Savara宣布，其关于Molgramostim吸入溶液（Molgramostim）治疗自身免疫性肺泡蛋白沉积症（aPAP）的III期临床试验结果，将在2026年欧洲呼吸学会（ERS）大会上以Encore形式再度呈现。此次展示是对该领域前沿研究的一次重要重申，亦为与会者提供了深入了解这一潜在疗法的机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181525658","title":"Savara旗下Molbreevi MAAS同步接受EMA与英国MHRA审查，预计分别于2027年Q1与2026年Q4揭晓结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1181525658","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181525658?lang=zh_cn&edition=full","pubTime":"2026-08-12 04:45","pubTimestamp":1786481154,"startTime":"0","endTime":"0","summary":"Savara Inc（Savara）正迎来关键监管节点。其药物Molbreevi的MAAS（市场授权申请）现已同时进入欧洲药品管理局（EMA）与英国药品和健康产品管理局（MHRA）的审查流程。根据最新时间表，EMA的决策窗口预计落在2027年第一季度，而MHRA则有望在2026年第四季度率先给出答案。这一进度差异，折射出不同监管机构各自的审评节奏与优先级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135683653","title":"Savara宣布欧洲和澳大利亚专利局授予Molbreevi*液体制剂专利，保护期至2041年3月","url":"https://stock-news.laohu8.com/highlight/detail?id=1135683653","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135683653?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:06","pubTimestamp":1785413196,"startTime":"0","endTime":"0","summary":"Savara Inc今日正式宣布，欧洲专利局与澳大利亚专利局已分别授予其核心药物Molbreevi*液体制剂的相关专利。这一里程碑式的进展，将为该公司在欧澳两大市场铺设一条长达近二十年的专利护城河。根据官方公告，这两项专利所提供的知识产权保护，将一直持续至2041年3月，为Savara的长期战略布局注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172355328","title":"Savara公司首席财务及行政官Dave Lowrance将于2026年7月15日卸任","url":"https://stock-news.laohu8.com/highlight/detail?id=1172355328","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172355328?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:06","pubTimestamp":1780949172,"startTime":"0","endTime":"0","summary":"Savara公司宣布，其首席财务及行政官Dave Lowrance将于2026年7月15日正式离职。公司正着手进行继任规划，以确保相关职责的平稳过渡。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144218221","title":"Savara在美国胸科学会2026年国际会议上公布其Molgramostim吸入溶液用于自身免疫性肺泡蛋白沉积症的Impala-2三期临床试验新生物标志物数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144218221","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144218221?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:15","pubTimestamp":1779279333,"startTime":"0","endTime":"0","summary":"Savara Inc. 在近日举行的美国胸科学会2026年国际会议上，公布了其核心候选药物Molgramostim吸入溶液针对自身免疫性肺泡蛋白沉积症（aPAP）的Impala-2三期临床试验的最新生物标志物数据。\n此次公布的数据进一步揭示了该疗法的潜在作用机制与生物活性。生物标志物的动态变化为评估药物在患者体内的疗效反应提供了关键的科学依据。数据的呈现增强了业界对该疗法临床路径的理解，也标志着Savara在推进这一罕见呼吸疾病治疗方案的进程中取得了新的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128565481","title":"Savara公布IMPALA-2三期临床试验中莫格司亭吸入溶液治疗自身免疫性肺泡蛋白沉积症的新运动能力数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1128565481","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128565481?lang=zh_cn&edition=full","pubTime":"2026-05-19 02:56","pubTimestamp":1779130579,"startTime":"0","endTime":"0","summary":"Savara公司公布了其IMPALA-2三期临床试验中，关于莫格司亭吸入溶液治疗自身免疫性肺泡蛋白沉积症的新运动能力数据。该试验旨在评估莫格司亭对这一罕见肺部疾病患者的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517794858","title":"Savara, Inc.盘中异动 急速上涨5.44%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517794858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517794858?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185084,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Savara, Inc.股票出现异动，股价大幅拉升5.44%。截至发稿，该股报2.52美元/股，成交量3.8759万股，换手率0.02%，振幅4.60%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为323.50%、252.09%、185.06%，振幅较大的相关个股有Aditxt, Inc.、Tango Therapeutics, Inc.、天境生物，振幅分别为23.90%、11.41%、11.10%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223124abe9b083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223124abe9b083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510090333","title":"Savara, Inc.盘中异动 早盘股价大跌5.02%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510090333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510090333?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:13","pubTimestamp":1739286836,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时13分，Savara, Inc.股票出现波动，股价急速下挫5.02%。截至发稿，该股报2.65美元/股，成交量5.2158万股，换手率0.03%，振幅4.30%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为1.53%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2542.50%、824.87%、338.67%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、43.92%、37.99%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112313569881c543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112313569881c543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507128620","title":"Savara, Inc.盘中异动 早盘快速上涨7.49%报2.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507128620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507128620?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:58","pubTimestamp":1738252738,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时58分，Savara, Inc.股票出现异动，股价快速拉升7.49%。截至发稿，该股报2.87美元/股，成交量15.1275万股，换手率0.09%，振幅3.75%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1590.55%、210.22%、196.46%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235858961447a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235858961447a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505864288","title":"Savara, Inc.盘中异动 早盘急速下挫5.03%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505864288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505864288?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:24","pubTimestamp":1737732252,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时24分，Savara, Inc.股票出现波动，股价快速下挫5.03%。截至发稿，该股报2.74美元/股，成交量4.2033万股，换手率0.02%，振幅3.99%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Transcode Therapeutics, Inc.、Pmgc Holdings Inc.、Dominari Holdings Inc.涨幅较大，Pmgc Holdings Inc.、Transcode Therapeutics, Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为1772.31%、1139.13%、903.95%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为66.25%、57.27%、55.79%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124232412abb75a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124232412abb75a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505028762","title":"Savara, Inc.盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505028762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505028762?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:54","pubTimestamp":1737662040,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时54分，Savara, Inc.股票出现波动，股价大幅上涨5.05%。截至发稿，该股报2.91美元/股，成交量32.0744万股，换手率0.19%，振幅6.41%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Transcode Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7072.30%、6676.27%、896.79%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Transcode Therapeutics, Inc.，振幅分别为948.57%、172.73%、142.40%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124035400a22d484a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124035400a22d484a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505578995","title":"Savara, Inc.盘中异动 大幅下挫5.12%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505578995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505578995?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:25","pubTimestamp":1737491124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时25分，Savara, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报2.78美元/股，成交量43.3674万股，换手率0.25%，振幅6.14%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为1.89%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1507.61%、527.94%、190.79%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、67.67%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122042525abb39106&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122042525abb39106&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504456999","title":"Savara, Inc.盘中异动 大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504456999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504456999?lang=zh_cn&edition=full","pubTime":"2025-01-17 02:00","pubTimestamp":1737050412,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日02时00分，Savara, Inc.股票出现异动，股价急速下挫5.02%。截至发稿，该股报2.94美元/股，成交量31.7074万股，换手率0.18%，振幅6.31%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.较为活跃，换手率分别为1897.90%、967.59%、690.98%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.，振幅分别为152.94%、131.33%、104.84%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011702001296063261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011702001296063261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503427076","title":"Savara, Inc.盘中异动 急速拉升5.15%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503427076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503427076?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951542,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Savara, Inc.股票出现波动，股价大幅上涨5.15%。截至发稿，该股报2.86美元/股，成交量5055股，换手率0.00%，振幅1.10%。Savara, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、53.26%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522322298673b5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522322298673b5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503158565","title":"Savara, Inc.盘中异动 股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503158565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503158565?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:41","pubTimestamp":1736779288,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时41分，Savara, Inc.股票出现异动，股价快速下跌5.40%。截至发稿，该股报2.63美元/股，成交量7.433万股，换手率0.04%，振幅4.14%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4070.19%、2318.34%、401.13%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、67.46%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224129aba933a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224129aba933a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502894923","title":"Savara, Inc.盘中异动 急速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502894923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502894923?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:49","pubTimestamp":1736527797,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时49分，Savara, Inc.股票出现异动，股价快速下跌5.10%。截至发稿，该股报2.89美元/股，成交量29.4848万股，换手率0.17%，振幅3.95%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为1.81%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1211.26%、799.22%、226.53%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111004957aba62256&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111004957aba62256&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494384911","title":"Savara, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494384911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494384911?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:25","pubTimestamp":1735313147,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时25分，Savara, Inc.股票出现波动，股价急速下挫5.03%。截至发稿，该股报3.12美元/股，成交量11.2629万股，换手率0.07%，振幅5.03%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Galectin Therapeutics Inc.、Traws Pharma, Inc.涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为101.77%、44.34%、20.19%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Moolec Science Sa C/Wts ，振幅分别为65.39%、58.33%、50.70%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723254795ef821c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723254795ef821c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492103388","title":"摩根大通证券公司：重申Savara评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492103388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492103388?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:48","pubTimestamp":1734623296,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申savara(SVRA.US)评级，由优于大市调整至优于大市评级,目标价由9.00美元调整至9.00美元。Savara(SVRA.US)公司简介：Savara Inc是一家生物制药公司。它专注于罕见的呼吸道疾病。该公司的主导项目molgramostim雾化溶液(molgramostim)是一种吸入性粒细胞-巨噬细胞集落刺激因子，处于自身免疫性肺泡蛋白沉积症(aPAP)的第3阶段开发阶段。它有一个部门专注于呼吸系统内的特殊药物。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219235508a1fb7b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219235508a1fb7b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492512179","title":"Savara, Inc.盘中异动 早盘急速上涨5.63%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492512179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492512179?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:31","pubTimestamp":1734618713,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时31分，Savara, Inc.股票出现波动，股价快速拉升5.63%。截至发稿，该股报3.19美元/股，成交量3.8932万股，换手率0.02%，振幅2.81%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为2.72%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mesoblast Ltd涨幅较大，Phio Pharmaceuticals Corp.、Elevai Labs, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为405.58%、309.76%、307.74%，振幅较大的相关个股有Genprex, Inc.、奥麦罗制药、Upstream Bio, Inc.，振幅分别为11.66%、11.26%、10.06%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223153ab849ebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223153ab849ebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492155392","title":"Savara, Inc.盘中异动 下午盘大幅下跌5.12%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492155392?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:05","pubTimestamp":1734552301,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时05分，Savara, Inc.股票出现异动，股价快速下挫5.12%。截至发稿，该股报3.06美元/股，成交量25.2532万股，换手率0.15%，振幅5.56%。Savara, Inc.股票所在的生物技术行业中，整体跌幅为2.02%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3186.24%、665.12%、346.61%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、138.10%、105.17%。Savara, Inc.公司简介：Savara Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904050195ea59d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904050195ea59d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.savarapharma.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":-0.0252},{"period":"3month","weight":-0.1375},{"period":"6month","weight":-0.0775},{"period":"1year","weight":0.0892},{"period":"ytd","weight":-0.2305}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Savara Inc.于1995年12月在特拉华州注册成立。该公司是一家专注于罕见呼吸道疾病的临床阶段生物制药公司。其唯一的项目molgramostim吸入溶液（MOLBREEVI）是一种研究性吸入式生物制剂，正处于治疗自身免疫性肺泡蛋白沉积症的3期开发阶段，并已获得快速通道、突破性疗法和孤儿药资格认定。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.103891},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.038506},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.017596},{"month":4,"riseRate":0.571429,"avgChangeRate":0.029792},{"month":5,"riseRate":0.642857,"avgChangeRate":0.021325},{"month":6,"riseRate":0.5,"avgChangeRate":-0.018175},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.03016},{"month":8,"riseRate":0.5,"avgChangeRate":0.01418},{"month":9,"riseRate":0.5,"avgChangeRate":0.007273},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.131702},{"month":11,"riseRate":0.5,"avgChangeRate":0.119333},{"month":12,"riseRate":0.538462,"avgChangeRate":0.21983}],"exchange":"NASDAQ","name":"Savara Inc","nameEN":"Savara Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Savara Inc(SVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Savara Inc,SVRA,Savara Inc股票,Savara Inc股票老虎,Savara Inc股票老虎国际,Savara Inc行情,Savara Inc股票行情,Savara Inc股价,Savara Inc股市,Savara Inc股票价格,Savara Inc股票交易,Savara Inc股票购买,Savara Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Savara Inc(SVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Savara Inc(SVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}